Prostate cancer
Prostate cancer is common but not all cancer is lethal.
Men want to know with certainty if they have it or not.
If they do have it, they want to know exactly how aggressive it is, to decide treatment options
Accurately assess prostate to identify any abnormalities prior to invasive biopsy.
Allows targeting of abnormalities rather then traditional blind random TRUS biopsy
Potentially avoid invasive biopsy if no abnormalities found and other tests do not highlight risk.
Requires expert specialist radiologists and an integrated team to ensure correctly utilised.
Precise targeted biopsy of all areas of the prostate, particularly some areas often missed with other biopsy techniques
Performed as a short day stay procedure under General Anaesthetic to avoid the discomfort of a local procedure
Avoids faecal contamination from the back passage with extremely low rates of infection
Biopsy results accurately reflect the aggressiveness of cancer found on final diagnosis
Negative biopsy result combined with MRI gives great certainty of knowing no significant cancer is present
Combines both powerful diagnostic tools into a highly precise method of diagnosing prostate cancer
Quickly becoming the gold standard for prostate cancer diagnosis
